Sartorius Stedim Biotech adds PESU membranes to benchtop filtration techs

By Staff reporter

- Last updated on GMT

Related tags: Protein, Biotechnology

Sartorius Stedim Biotech adds PESU membranes to benchtop filtration techs
Sartorius Stedim Biotech (SSB) claims benchtop vaccine and protein purification techs could save developers €2000 per batch and reduce processing time by 60%.

The new filtration assemblies – which is part of SSB’s Sartocon range – are based on the firm’s polyethersulfone membrane (PESU), which filter proteins and vaccines based on their molecular weight across a broad pH and temperature range.

Previously the Sartocon systems used SSB’s Hydrosart membranes according to spokesman Frank Meyeroltmanns, who said: “Now customers can select from a broader range of membrane polymers and cut offs for ensuring optimal parameter for their specific process​.”

He added that: “When compared with reusable filter cassettes, we estimate that using these new single-use, PESU membrane-based assemblies will reduce processing time by around 60 percent and could save up to €2,000 per batch on buffer and water costs​.”

The single-use system filtration assemblies are also so called "closed loop" systems, which means they are fully enclosed and can be used in current Good Manufacturing Practices (cGMP) environments for a broad range of applications.

This flexibility makes the system ideal for contract manufacturing organisations (CMO) and other organizations operating multi-product production facilities according to SSB.

The launch follows just a month​ after SSB bundled its upstream technologies into a single offering – called Connect Upstream.

At the time the firm said the move was already designed to help developers get products to market quicker and more cheaply.

Related news

Show more

Related products

show more

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 06-Dec-2022 | Product Brochure

Your biologics possess a high level of complexities and technical challenges. That’s why development is key to ensuring the successful delivery of your...

Related suppliers

Follow us

Products

View more

Webinars